Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
Clinical trial NCT00694148 · COMPLETED
Trial details
- NCT number
- NCT00694148
- Sponsor
- Merz Pharmaceuticals GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-01-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.